Liver injury due to sequential activation of natural killer cells and natural killer T cells by carrageenan.

[1]  M. Smyth,et al.  Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells , 2001, Nature Medicine.

[2]  J. Penninger,et al.  Adhesion mediated by LFA‐1 is required for efficient IL‐12‐induced NK and NKT cell cytotoxicity , 2000, European journal of immunology.

[3]  S. Govindarajan,et al.  NK Cells Cause Liver Injury and Facilitate the Induction of T Cell-Mediated Immunity to a Viral Liver Infection1 , 2000, The Journal of Immunology.

[4]  K. Hatakeyama,et al.  Disparate effect of beige mutation on cytotoxic function between natural killer and natural killer T cells , 2000, Immunology.

[5]  T. Abo,et al.  Physiological responses of extrathymic T cells in the liver , 2000, Immunological reviews.

[6]  T. Tada,et al.  Mechanisms underlying immunologic states during pregnancy: possible association of the sympathetic nervous system. , 1999, Cellular immunology.

[7]  H. Watanabe,et al.  Expansion of extrathymic T cells as well as granulocytes in the liver and other organs of granulocyte-colony stimulating factor transgenic mice: why they lost the ability of hybrid resistance. , 1999, Journal of immunology.

[8]  H. Moriwaki,et al.  IL-12 induces specific cytotoxicity against regenerating hepatocytes in vivo. , 1999, International immunology.

[9]  C. Miyaji,et al.  Abundance of NKT cells in the salivary glands but absence thereof in the liver and thymus of aly/aly mice with Sjögren syndrome. , 1999, Cellular immunology.

[10]  S. Akira,et al.  IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock. , 1999, International immunology.

[11]  T. Tada,et al.  Low level of mixing of partner cells seen in extrathymic T cells in the liver and intestine of parabiotic mice: its biological implication , 1998, European journal of immunology.

[12]  Y. Tanaka,et al.  Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Hiroshi Sato,et al.  Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors , 1997 .

[14]  H. Watanabe,et al.  Intermediate TCR cells in mouse lung: their effector function to induce pneumonitis in mice with autoimmune-like graft-versus-host disease. , 1997, Journal of immunology.

[15]  T. Tada,et al.  Autologous killing by a population of intermediate T‐cell receptor cells and its NK1.1+ and NK1.1− subsets, using Fas ligand/Fas molecules , 1997, Immunology.

[16]  Seokmann Hong,et al.  CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. , 1997, Immunity.

[17]  M. Kaplan,et al.  Immunoglobulin E Production in the Absence of Interleukin-4-Secreting CD1-Dependent Cells , 1997, Science.

[18]  K. Hatakeyama,et al.  Restricted appearance of self‐reactive clones into T cell receptor intermediate cells in neonatally thymectomized mice with autoimmune disease , 1996, European journal of immunology.

[19]  I. Yano,et al.  Kinetics of Organ‐Associated Natural Killer Cells and Intermediate CD3 Cells during Pulmonary and Hepatic Granulomatous Inflammation Induced by Mycobacterial Cord Factor , 1996, Microbiology and immunology.

[20]  A. Zlotnik,et al.  Mouse NK1.1+ T cells: a new family of T cells. , 1996, Immunology today.

[21]  H. Watanabe,et al.  Adhesion molecules on intermediate TCR cells. II. Hepatoprotective effects of hyaluronic acid on acute liver injury. , 1995, Cellular immunology.

[22]  H. Takahashi-Iwanaga,et al.  Relationships between intermediate TCR cells and NK1.1+ T cells in various immune organs. NK1.1+ T cells are present within a population of intermediate TCR cells. , 1995, Journal of immunology.

[23]  H. Macdonald.  NK1.1+ T cell receptor-alpha/beta+ cells: new clues to their origin, specificity, and function , 1995, The Journal of experimental medicine.

[24]  R. Locksley,et al.  Natural T cells. Cells that co-express NKRP-1 and TCR. , 1995, Journal of immunology.

[25]  T. Hanyu,et al.  Adhesion molecules on intermediate TCR cells. I. Unique expression of adhesion molecules, CD44+ L-selectin-, on intermediate TCR cells in the liver and the modulation of their adhesion by hyaluronic acid. , 1995, Immunology.

[26]  A. Bendelac.  Mouse NK1+ T cells. , 1995, Current opinion in immunology.

[27]  Hans Hengartner,et al.  Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice , 1994, Nature.

[28]  S. Suzuki,et al.  The role of natural killer cells and lymphokine activated killer cells in the pathogenesis of hepatic injury in hepatitis A [corrected]. , 1992, Journal of clinical & laboratory immunology.

[29]  K. Kaneda.  Liver-associated large granular lymphocytes: morphological and functional aspects. , 1989, Archives of histology and cytology.

[30]  W. Chambers,et al.  The effects of hexose 6-O-sulfate esters on human natural killer cell lytic function. , 1986, Journal of immunology.

[31]  J. W. Dennis,et al.  Recognition of asparagine-linked oligosaccharides on murine tumor cells by natural killer cells. , 1985, Cancer research.

[32]  P. Quan,et al.  NK activity in carrageenan-treated mice. , 1980, Immunology.

[33]  O. Stutman,et al.  Natural cytotoxic cells against solid tumors in mice: blocking of cytotoxicity by D-mannose. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Lowes,et al.  A histopathological study of the effects of intravenously administered lambda carrageenan in the mouse, with particular reference to the macrophage system. , 1979, British journal of experimental pathology.

[35]  A. Thomson,et al.  Effect of carrageenan on activity of the mononuclear phagocyte system in the mouse. , 1978, British journal of experimental pathology.

[36]  G. Cudkowicz,et al.  Abrogation of Resistance to Foreign Bone Marrow Grafts by Carrageenans , 1977, The Journal of Immunology.

[37]  G. Cudkowicz,et al.  Abrogation of resistance to foreign bone marrow grafts by carrageenans. I. Studies with the anti-macrophage agent seakem carrageenan. , 1977, Journal of immunology.

[38]  A. Thomson,et al.  Alleviation of carrageenan-induced hepatotoxicity and acronecrosis by aprotinin. , 1977, British journal of experimental pathology.

[39]  E. Lotzová,et al.  Promotion of incidence of adenovirus type 12 transplantable tumors by carrageenan, a specific antimacrophage agent. , 1977, Journal of the National Cancer Institute.

[40]  A. Thomson,et al.  Toxicity of various carrageenans in the mouse. , 1976, British journal of experimental pathology.

[41]  E. Lotzová,et al.  Involvement of macrophages in genetic resistance to bone marrow grafts. Studies with two specific antimacrophage agents, carrageenan and silica. , 1975, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

[42]  M. Rosa.  Biological properties of carrageenan , 1972 .

[43]  R. Graham,et al.  Spectrum and possible mechanism of carrageenan cytotoxicity. , 1971, The American journal of pathology.

[44]  M. Lutzner,et al.  Giant granules in leukocytes of the beige mouse. , 1967, The Journal of heredity.

[45]  A. C. Allison,et al.  AN EXAMINATION OF THE CYTOTOXIC EFFECTS OF SILICA ON MACROPHAGES , 1966, The Journal of experimental medicine.